Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
565-04-004 ISMRM Abstract

Visual vs. Radiomics Assessment of Post-contrast T2 FLAIR - T1WI Enhancement Mismatch for IDH1 Prediction

Primary: Neuro - Tumors
Secondary: Analysis Methods - Classification and Prediction
565-04-004 · Neuroradiomics · Wednesday, 13 May, 2:35 PM–3:30 PM · Digital Posters Row F
Keywords: Radiomics IDH mutation VASARI features CE-T2 FLAIR Adult-type diffuse glioma
Accepted
Hongzhong Liang 1, Ruixiang Wei2, Huimin Wang1, Kang Chen2, Mengxia Zhang1, Zhihuan Li1, Miyuan Hu1, Jiale Zhu2, Rui Guo1, Ying Qin1, Jun Peng3, Yunping Xiao1
1Department of Radiology, Liuzhou People’s Hospital Affiliated to Guangxi Medical University, Liuzhou, China
2Department of Neurosurgery, Liuzhou People’s Hospital Affiliated to Guangxi Medical University, Liuzhou, China
3Department of Clinical & Technical Solutions, Philips Healthcare, Guangzhou, China
Presenting Author: Hongzhong Liang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Louis D N, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol, 2021, 23(8): 1231-1251. DOI: 10.1093/neuonc/noab106 [doi]
2. Ahn SJ, Taoka T, Moon WJ, et al. Contrast-Enhanced Fluid-Attenuated Inversion Recovery in Neuroimaging: A Narrative Review on Clinical Applications and Technical Advances. J Magn Reson Imaging, 2022, 56(2): 341-353. DOI: 10.1002/jmri.28117 [doi]
3. Heyn C, Bishop J, Moody AR, et al. Gadolinium-Enhanced T2 FLAIR Is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain Metastases. AJNR Am J Neuroradiol, 2025, 46(1): 129-135. DOI: 10.3174/ajnr.A8431 [doi]
4. Park YW, Jang G, Kim SB, et al. Leptomeningeal Metastases in IDH-wildtype Glioblastomas Revisited: Comprehensive Analysis of Incidence, Risk Factors, and Prognosis Based on Post-contrast FLAIR. Neuro Oncol, 2024, 26(10):1921-1932. DOI: 10.1093/neuonc/noae091 [doi]
5. Chul Lee Y, Suh S, Ryoo I, et al. Imaging finding and analysis of brain lymphoma in contrast-enhanced fluid attenuated inversion recovery sequence. Eur J Radiol, 2022, 155: 110490. DOI : 10.1016/j.ejrad.2022.110490 [doi]
6. Gao X Y, Wang Y D, Wu S M, et al. Differentiation of Treatment-Related Effects from Glioma Recurrence Using Machine Learning Classifiers Based Upon Pre-and Post-Contrast T1WI and T2 FLAIR Subtraction Features: A Two-Center Study. Cancer Manag Res, 2020, 12: 3191-3201. DOI: 10.2147/cmar.S244262 [doi]
7. Rui W, Jin T, Zhang H, et al. Optimization of Contrast Agent Dosage on Contrast-Enhanced T2 Fluid-Attenuated Inversion Recovery: An In Vitro and In Vivo Study. J Comput Assist Tomogr, 2021, 45(1): 121-127. DOI: 10.1097/rct.0000000000001055 [doi]
8. Gutman DA, Cooper LA, Hwang SN, et al. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology, 2013, 267(2): 560-569. DOI: 10.1148/radiol.13120118 [doi]
9. Zwanenburg A, Vallières M, Abdalah MA, et al. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology, 2020, 295(2): 328-338. DOI: 10.1148/radiol.2020191145 [doi]
10. Gemini L, Tortora M, Giordano P, et al. Vasari Scoring System in Discerning between Different Degrees of Glioma and IDH Status Prediction: A Possible Machine Learning Application? J Imaging, 2023, 9(4): 75. DOI: 10.3390/jimaging9040075 [doi]
11. Azizova A, Prysiazhniuk Y, Wamelink I, et al. Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance AJNR Am J Neuroradiol, 2024, 45(8): 1053-1062. DOI: 10.3174/ajnr.A8274 [doi]
12. Setyawan NH, Choridah L, Nugroho HA, et al. Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas Cancer Imaging, 2024, 24(1): 3. DOI: 10.1186/s40644-023-00638-8 [doi]
13. Jin T, Ge M, Huang R, et al. Utility of Contrast-Enhanced T2 FLAIR for Imaging Brain Metastases Using a Half-dose High-Relaxivity Contrast Agent. AJNR Am J Neuroradiol, 2021, 42(3): 457-463. DOI: 10.3174/ajnr.A6931 [doi]
14. Jin T, Zhang H, Liu X, et al. Enhancement degree of brain metastases: correlation analysis between enhanced T2 FLAIR and vascular permeability parameters of dynamic contrast-enhanced MRI. Eur Radiol, 2021, 31(8): 5595-5604. DOI: 10.1007/s00330-020-07625-8 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/565-04-004